TNXP
Tonix Pharmaceuticals Holding Corp.
Latest Form 4:Purchase$28KbyLEDERMAN SETH (Chief Executive Officer) · filed Aug 31, 2026
Tonix Pharmaceuticals Holding Corp. (TNXP) has 8 SEC Form 4 filings (8 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Aug 31, 2026.
The most active filer is Chief Executive Officer LEDERMAN SETH with 4 filings. Insiders have net bought $459K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Seth Lederman
- Employees:142
- HQ:Berkeley Heights, NJ, US
- IPO:2012-05-10
Insider Buying
$459K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$216.6M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Executive Officer | Purchase | 2,000 | $28K | Aug 31 | SEC ↗ | |
BAGGER RICHARD HFirst filing | Director | Purchase | 1,000 | $13K | Aug 24 | SEC ↗ |
Taylor Carolyn E.First filing | Director | Purchase | 1,415 | $15K | Jun 15 | SEC ↗ |
Stillwell Richard NewcombFirst filing | Director | Purchase | 5,000 | $58K | Jun 9 | SEC ↗ |
| Chief Executive Officer | Purchase | 5,000 | $59K | Jun 9 | SEC ↗ | |
| Chief Executive Officer | Purchase | 5,000 | $63K | Apr 1 | SEC ↗ | |
LEDERMAN SETHFirst filing | Chief Executive Officer | Purchase | 15,000 | $223K | Mar 18 | SEC ↗ |
Related companies
Tonix Pharmaceuticals Holding Corp. is in the Healthcare sector.